Cleared Traditional

K131891 - ECLIPSE TREATMENT PLANNING SYSTEM

K131891 is an FDA 510(k) clearance for ECLIPSE TREATMENT PLANNING SYSTEM, manufactured by Varian Medical Systems, Inc.. The device is a Class 2 Radiology device with product code MUJ cleared through the Traditional 510(k) pathway after a 92-day FDA review.

K131891 · Varian Medical Systems, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2013
Decision
92d
Days
Class 2
Risk

K131891 is an FDA 510(k) clearance for the ECLIPSE TREATMENT PLANNING SYSTEM. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Varian Medical Systems, Inc. (Palo Alto, US). The FDA issued a Cleared decision on September 25, 2013 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Varian Medical Systems, Inc. devices

FDA 510(k) Submission Details - K131891

510(k) Number K131891 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 2013
Decision Date September 25, 2013
Days to Decision 92 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 107d · This submission: 92d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MUJ Device Classification - Class 2, Special Controls

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 212
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K131891.
RADIANCE V2
K133655 · Gmv Soluciones Globales Internet S.A.U. · Jan 2014
4D INTEGRATED TREATMENT CONSOLE
K133331 · Varian Medical Systems, Inc. · Jan 2014
MONACO
K132971 · Impac Medical Systems, Inc. · Nov 2013
RADVISION
K131428 · Acoustic Medsystems, Inc. · Jul 2013
RAYSTATION
K130617 · Raysearch Laboratories AB · May 2013
HDRPLUS, ADD IN PROSTATE MODULE FOR HDRPLUS
K123263 · Eckert & Ziegler Bebig GmbH · Apr 2013